Ovarian cancer treatment is complex and includes a variety of therapeutic options. A relatively new class of drugs, PARP inhibitors, are increasingly showing promise in the fight against ovarian cancer. Most recently, the American Society of Clinical Oncology (ASCO) released new guidelines recommending PARP inhibitors be offered to women, with or without genetic mutations, who are newly diagnosed with stage III or IV ovarian cancer and have improved with chemotherapy. But they also comes with some unfortunate side effects.
“When we first tested some of these PARP inhibitors in the recurrent patients, we thought they would be well tolerated, not just from a convenience profile, but also from a toxicity profile,” says Dr. John Chan, gynecologic oncologist at Sutter Bay Medical Foundation in the Bay Area. “We were surprised that these oral therapies, even though they are just pills, can give patients more side effects, even compared to intravenous chemotherapy.” But PARP inhibitors are still an invaluable tool in ovarian cancer treatment.
Common Side Effects of PARP Inhibitors
Recent studies suggest that using PARP inhibitors — either as first-line therapy, maintenance therapy, or both, significantly extends the length of time patients are cancer-free or before their cancer worsens.
These studies tested the following therapies among women with high-grade epithelial cancers:
Whether or not you’ll experience significant side effects from PARP inhibitors depends on a number of factors, including which PARP inhibitor you’re taking, what dose you’re ingesting, and whether you’re using it alone or in combination with other therapies.
Still, the side effects of some PARP inhibitor protocols do overlap and include:
Toward Reduced Toxicities
Since PARP inhibitors disrupt how cells repair damaged DNA, killing off tumor cells and healthy cells simultaneously, fatigue, bone marrow suppression and nausea make sense. But doctors can take steps up front to help patients better navigate treatment.
“Before patients start on PARP inhibitors, it’s important to make sure that they’ve recovered from suppressive drugs that they received intravenously,” Dr. Chan says. “Once they start, it’s important to continue monitoring them to make sure that their bone marrow is not compromised.”
If side effects are interfering with the patient’s health or quality of life, there are a number of things doctors and patients can do to minimize the side effects of PARP inhibitor treatment.
On the physician side:
On the patient side:
Dr. Amanika Kumar of the Mayo Clinic who spoke to SurvivorNet, cautioned that women still need to speak with their doctor to evaluate the benefit of taking a PARP inhibitor to extend life, because there are very real side effects due to the toxicity of the drug. “Patients with HRD (homologous recombination deficiency) have a far better response than those without and those with BRCA mutations even more so. It is on us as clinicians to help patients understand the risks and benefits of treatment. Patients that have no mutation or HRD may choose not to go on maintenance (in fact I recommend they don’t) because there is real toxicity to these meds.”
If treatment with PARP inhibitors doesn’t feel right to you, to talk to your doctor about alternatives. Ovarian cancer treatment is complex, but doctors have more tools at their disposal than ever before.
We Are So Much Stronger Than We Realize - Ovarian Cancer Survivor Helene Unger On How She Found the Strength to Fight
How Two-Time Survivor Bianca Muniz Learned to Not Take Life So Seriously
"F*ck You, Cancer -- But I Say It With A Smile": Ovarian Cancer Survivor Noelle Kouris Shares Her Story
Facing An Ovarian Cancer Diagnosis Mid-Career -- Ex-NYPD Sergeant Shares Her Story
Finding a Way to Live, Learn, and Cope With a Cancer Recurrence
Sex and Cancer: Getting Intimate After Ovarian Cancer
You Need Time to Talk: Survivor Annie Ellis on Cancer Support Groups